Aptorum Group Limited redomiciled as Niki BioSolutions, Inc. and completed its merger with DiamiR Biosciences Corp. on July 20, 2026. The transaction involved a 1-for-10 reverse stock split of Aptorum's authorized share capital. Niki BioSolutions, Inc. is a biopharmaceutical company focused on therapeutic assets for oncology and infectious diseases.
